DGAT2 and glioblastoma: Moreover, an even higher dose of A922500 (47 μM) was unable to suppress LD dependent on DGAT2 or to markedly suppress viability in glioblastoma cells over-expressing DGAT2 (Cheng et al., 2020), consistent with A922500 being a selective DGAT1 inhibitor at this concentration.